Cargando…

Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study

PURPOSE: We evaluated the feasibility of patient symptom self-reporting using a web-based interface (WBI), with automated message alerts for severe and/or worsening symptoms, in patients undergoing definitive chemoradiation therapy (CRT). METHODS AND MATERIALS: Patients receiving definitive CRT for...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ting Martin, Yang, Tiffany, Philipson, Rebecca, Kishan, Amar U., Lee, Percy, Raldow, Ann C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238265/
https://www.ncbi.nlm.nih.gov/pubmed/37273926
http://dx.doi.org/10.1016/j.adro.2022.101073
_version_ 1785053255897710592
author Ma, Ting Martin
Yang, Tiffany
Philipson, Rebecca
Kishan, Amar U.
Lee, Percy
Raldow, Ann C.
author_facet Ma, Ting Martin
Yang, Tiffany
Philipson, Rebecca
Kishan, Amar U.
Lee, Percy
Raldow, Ann C.
author_sort Ma, Ting Martin
collection PubMed
description PURPOSE: We evaluated the feasibility of patient symptom self-reporting using a web-based interface (WBI), with automated message alerts for severe and/or worsening symptoms, in patients undergoing definitive chemoradiation therapy (CRT). METHODS AND MATERIALS: Patients receiving definitive CRT for gastrointestinal, lung, and head and neck cancers with access to a computer and/or mobile device were eligible. Symptom self-reporting was conducted via a WBI through surveys adapted from the patient-reported outcomes version of the Common Terminology Criteria for Adverse Events: 2 per week during CRT and 1 per week for 3 months after CRT. Nurses were alerted whenever a patient's symptom worsened by ≥2 points or reached a score of ≥3. Patient-Reported Outcomes Measurement Information System (PROMIS) surveys were conducted at baseline, end of CRT, and 3 months after CRT. Patients also completed exit surveys 3 months after CRT. RESULTS: Nineteen patients were enrolled with a median of 30 fractions (range, 28-33). The median survey completion rate was 26% (range, 0%-100%) during CRT and 33% (range, 0%-100%) during the first 3 months after CRT. Five (26%) had acute hospital encounters during CRT or within 3 months of CRT completion. Two patients (11%) experienced CRT treatment interruptions. During CRT, 70 of 81 surveys (86%) were flagged and 61 of 70 (87%) were acted upon by a nurse or physician within 4 days; during the first 3 months after CRT, 47 of 85 (55%) were flagged and 28 of 47 (60%) were acted upon within 7 days. Ninety-two percent of patients found it always easy to access the survey while 58% found the surveys too long or too frequent. None of the PROMIS domains had statistically significant changes during any time points. CONCLUSIONS: Symptom self-reporting via a WBI is feasible during definitive chemoradiation with high patient satisfaction. Survey fatigue is common and may be mitigated by improving the WBI to make it more patient-centered and allowing patients to choose which symptoms to report.
format Online
Article
Text
id pubmed-10238265
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102382652023-06-04 Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study Ma, Ting Martin Yang, Tiffany Philipson, Rebecca Kishan, Amar U. Lee, Percy Raldow, Ann C. Adv Radiat Oncol Scientific Article PURPOSE: We evaluated the feasibility of patient symptom self-reporting using a web-based interface (WBI), with automated message alerts for severe and/or worsening symptoms, in patients undergoing definitive chemoradiation therapy (CRT). METHODS AND MATERIALS: Patients receiving definitive CRT for gastrointestinal, lung, and head and neck cancers with access to a computer and/or mobile device were eligible. Symptom self-reporting was conducted via a WBI through surveys adapted from the patient-reported outcomes version of the Common Terminology Criteria for Adverse Events: 2 per week during CRT and 1 per week for 3 months after CRT. Nurses were alerted whenever a patient's symptom worsened by ≥2 points or reached a score of ≥3. Patient-Reported Outcomes Measurement Information System (PROMIS) surveys were conducted at baseline, end of CRT, and 3 months after CRT. Patients also completed exit surveys 3 months after CRT. RESULTS: Nineteen patients were enrolled with a median of 30 fractions (range, 28-33). The median survey completion rate was 26% (range, 0%-100%) during CRT and 33% (range, 0%-100%) during the first 3 months after CRT. Five (26%) had acute hospital encounters during CRT or within 3 months of CRT completion. Two patients (11%) experienced CRT treatment interruptions. During CRT, 70 of 81 surveys (86%) were flagged and 61 of 70 (87%) were acted upon by a nurse or physician within 4 days; during the first 3 months after CRT, 47 of 85 (55%) were flagged and 28 of 47 (60%) were acted upon within 7 days. Ninety-two percent of patients found it always easy to access the survey while 58% found the surveys too long or too frequent. None of the PROMIS domains had statistically significant changes during any time points. CONCLUSIONS: Symptom self-reporting via a WBI is feasible during definitive chemoradiation with high patient satisfaction. Survey fatigue is common and may be mitigated by improving the WBI to make it more patient-centered and allowing patients to choose which symptoms to report. Elsevier 2022-10-25 /pmc/articles/PMC10238265/ /pubmed/37273926 http://dx.doi.org/10.1016/j.adro.2022.101073 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Scientific Article
Ma, Ting Martin
Yang, Tiffany
Philipson, Rebecca
Kishan, Amar U.
Lee, Percy
Raldow, Ann C.
Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study
title Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study
title_full Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study
title_fullStr Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study
title_full_unstemmed Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study
title_short Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study
title_sort web-based symptom monitoring with patient-reported outcomes during definitive radiation therapy with chemotherapy (sympathy): a prospective single-center phase 1 study
topic Scientific Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238265/
https://www.ncbi.nlm.nih.gov/pubmed/37273926
http://dx.doi.org/10.1016/j.adro.2022.101073
work_keys_str_mv AT matingmartin webbasedsymptommonitoringwithpatientreportedoutcomesduringdefinitiveradiationtherapywithchemotherapysympathyaprospectivesinglecenterphase1study
AT yangtiffany webbasedsymptommonitoringwithpatientreportedoutcomesduringdefinitiveradiationtherapywithchemotherapysympathyaprospectivesinglecenterphase1study
AT philipsonrebecca webbasedsymptommonitoringwithpatientreportedoutcomesduringdefinitiveradiationtherapywithchemotherapysympathyaprospectivesinglecenterphase1study
AT kishanamaru webbasedsymptommonitoringwithpatientreportedoutcomesduringdefinitiveradiationtherapywithchemotherapysympathyaprospectivesinglecenterphase1study
AT leepercy webbasedsymptommonitoringwithpatientreportedoutcomesduringdefinitiveradiationtherapywithchemotherapysympathyaprospectivesinglecenterphase1study
AT raldowannc webbasedsymptommonitoringwithpatientreportedoutcomesduringdefinitiveradiationtherapywithchemotherapysympathyaprospectivesinglecenterphase1study